16 July 2025
Silverwood Brands Plc
("Silverwood" or the "Company", together with its subsidiaries, the "Group")
Deferred Consideration Share Distribution; Director/PDMR Shareholding
Silverwood Brands plc (AQSE: SLWD), a holding company established to invest primarily in branded consumer businesses, announces that 1,049,050 ordinary shares of 10 pence each in the Company have been allotted as deferred consideration at a deemed price of 85p per share, in accordance with the terms of the agreement for the acquisition of Balmonds Skincare Limited ("Balmonds") dated 14 June 2022 (the "Deferred Consideration Shares").
891,692 of the Deferred Consideration Shares have been allotted to Andrew Gerrie, a director of the Company, and his wife, Alison Hawksley. Following the issue of the Deferred Consideration Shares, Andrew Gerrie and Alison Hawksley are interested, jointly and individually, in a total of 9,779,629 Ordinary Shares, representing 22.46% of the Company's enlarged issued share capital.
Application will be made for the Deferred Consideration Shares to be admitted to trading on the Access Segment of the Aquis Growth Market and dealings in the Deferred Consideration Shares are expected to commence on 21 July 2025 ("Admission").
On Admission, the Deferred Consideration Shares will rank pari passu in all respects with the existing Ordinary Shares and will rank in full for all dividends and other distributions hereafter declared, paid or made on the ordinary share capital of the Company.
Paul Hodgins, Silverwood Director, said, "Over the last three years Balmonds has outperformed the minimum performance targets we set for their earnout. This is now the last compensation due for the acquisition of Balmonds, and we believe there remains significant potential to continue to grow the brand. Our partnership with Holland & Barrett remains strong. We are now in Boots, and we recently launched two new sunscreens for people with sensitive skin. Moreover, Balmonds has now sold more than 2 million pots of Skin Salvation since its introduction, proving the staying power and quality of our products."
Total Voting Rights
Following Admission, the Company's enlarged share capital will comprise 43,549,226 Ordinary Shares. The figure of 43,549,226 Ordinary Shares may be used by shareholders in the Company as the denominator for the calculation by which they may determine if they are required to notify their interest in, or a change in their overall interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.
For more information, please contact:
| Silverwood Brands Plc Andrew Gerrie Paul Hodgins
|
|
| Peterhouse Capital Limited (Aquis Corporate Adviser) Mark Anwyl Narisha Ragoonanthun Brefo Gyasi |
+44 (0)20 7469 0930 |
| 1 |
Details of the person discharging managerial responsibilities / person closely associated |
|||||
| a) |
Name |
Andrew Gerrie & Alison Hawksley |
||||
| 2 |
Reason for the notification |
|||||
| a) |
Position/status |
Executive Director & PCA |
||||
| b) |
Initial notification /Amendment |
Initial notification |
||||
| 3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||
| a) |
Name |
Silverwood Brands PLC |
||||
| b) |
LEI |
213800MOKU1KYZUFYZ40 |
||||
| 4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||
| a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 10p each ISIN: GB00BNRRGD95 |
||||
| b) |
Nature of the transaction |
Allotment of Ordinary Shares as deferred consideration |
||||
| c) |
Price(s) and volume(s) |
|
||||
| d)
|
Aggregated information: - Aggregated volume - Price
|
n/a single transaction |
||||
| e) |
Date of the transaction |
16 July 2025 |
||||
| f) |
Place of the transaction |
Off market transaction |
||||
Market Abuse Regulation (MAR) Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation EU 596/2014 as it forms part of retained EU law (as defined in the European Union (Withdrawal) Act 2018).
The Directors of the Company accept responsibility for the contents of this announcement.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.